Compare Johnson & Johnson (JNJ) vs ServiceNow Inc (NOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs ServiceNow Inc — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while ServiceNow Inc trades at $140.86 (market cap $144.48B). The key difference: Johnson & Johnson is far larger — about 4.3× ServiceNow Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while ServiceNow Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and ServiceNow Inc for 54 Days on average.
| JNJ | NOW | |
|---|---|---|
Market Cap | $618.09B | $144.48B |
Volume | 6,050,983 | 11,801,699 |
Sector | Health | Technology |
52-Week High | $278.43 | $189.26 |
52-Week Low | $186.00 | $83.00 |
Typical Hold Time | 129 Days | 54 Days |
Enterprise Value | $646.37B | $148.27B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
ServiceNow (NOW) trades at $139.75, up 1.36% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with $13.28B revenue in 2025, 74.77% gross margins, and consistent earnings beats. Recent AI product growth exceeding $1B annual contract value and positive market sentiment position the stock for potential upside toward the $146.04 consensus target.
Outlook remains positive with AI-driven growth catalysts, though premium valuation (P/E 87.34) and competitive pressures present risks. Wall Street maintains strong buy sentiment (87% buy ratings) with institutional confidence in the company's enterprise software leadership and AI integration strategy supporting long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →
